WCM-Q named Best Research Office 2019 by QNRF
WCM-Q was named Best Research Office 2019 by QNRF at a ceremony held at QNCC.
Weill Cornell Medicine-Qatar (WCM-Q) has been named the Best Research Office for 2019 at the 11th Annual Forum of Qatar National Research Fund (QNRF).
The honor was bestowed by QNRF on WCM-Q, a QF partner institution, for showing diligence in support of QNRF’s processes and research efforts.
WCM-Q was also awarded grants for nine research proposals for studies investigating breast cancer, diabetes, heart disease, dementia and the potential impact of climate change on the built environment in Doha, among others. In addition, WCM-Q will serve as a sub-awardee on five other research grants awarded to collaborating institutions.
Following the event at Qatar National Convention Centre (QNCC), Dr. Khaled Machaca, Senior Associate Dean for Research, Innovations, and Commercialization at WCM-Q, said: “I am sure everyone at WCM-Q will join me in congratulating our research administration staff on winning the QNRF ‘Best Research Office Award’, which is truly a magnificent honor. We are very grateful that our team has been commended in this way for their exceptional dedication and commitment.”
He added: “We are also very appreciative to have once again received extremely strong support from QNRF for our research activities that are targeted toward tackling the health needs of Qatar by understanding them at the basic and clinical levels. QNRF has been a regional pillar in supporting research activities in Qatar and internationally. Despite its young age, QNRF has established the structure of a phenomenally successful funding agency, which is a unique achievement. QNRF’s research support represents one of the primary drivers toward the goal contained within Qatar National Vision 2030 of establishing a knowledge-based economy.
“WCM-Q is greatly honored to receive this recognition.”
The research program at WCM-Q was established in 2009 with the goal of pursuing cutting-edge biomedical research at the basic, translational and community levels, with a special focus on conditions that are prevalent in Qatar, such as diabetes, obesity and associated complications.
WCM-Q received support for eight proposals in the 12th cycle of QNRF’s National Priorities Research Program (NPRP 12-S) and one grant under the Path Towards Precision Medicine (PPM 3) program. In addition, WCM-Q will serve as a sub-awardee on four NPRP12-S grants and one PPM 3 grant submitted by collaborating institutions.
The full list of WCM-Q awardees is as follows:
NPRP 12-S
|
|
Title
|
WCM-Q Principal Investigator
|
|
Cancer Metabolism: Target and Predictor of Therapeutic Intervention in Breast Cancer
|
Dr. Anna Halama
|
|
Physiological association between diabetes mellitus and cardiac arrhythmia
|
Prof. Khaled Machaca
|
|
Corneal Confocal Microscopy: A rapid diagnostic and prognostic imaging biomarker for neurodegeneration in dementia
|
Prof. Rayaz Malik
|
|
Characterizing hepatitis C virus epidemiology in Qatar and the Middle East and North Africa: Screening strategies and the path to HCV elimination by 2030
|
Prof. Laith Abu-Raddad
|
|
Molecular and genomic epidemiology of invasive, multi drug resistant gram-negative bacteria in the State of Qatar.
|
Dr. Ali Sultan
|
|
Development of a non-invasive assay for allograft failure prognosis in kidney transplants
|
Dr. Abdelaziz Belkadi
|
|
UBR5, E3 Ubiquitin ligase, in Triple Negative Breast Cancers: Potential role in anti-Tumor Immunity and Cancer Metabolism
|
Prof. Lotfi Chouchane
|
|
Revealing the potential of pathogen-specific antibodies in diabetes patients with the aim of obtaining new diagnostic and prognostic signatures
|
Dr. Frank Schmidt
|
|
The Resiliency of Doha's Built Environment to Regional Climate Change
|
Dr. Ali Sultan*
|
|
Microneedle Arrays Patch Releasing Oxygen and Nitric Oxide for Diabetic Wounds and Ulcer Treatment
|
Dr. Nasrin Mesaeli*
|
|
A Novel Contactless ANFIS-EMG System for Diabetic Sensorimotor Polyneuropathy (DSPN)
|
Prof. Rayaz Malik*
|
|
From molecular etiology to improved reproductive health for male infertility in Qatar (The FERTILITY-IQ Study)
|
Dr. Amal Robay
|
|
*WCM-Q serving as sub-awardee
|
|
PPM 3
|
|
Title
|
WCM-Q PI
|
|
Precision Pharmacogenomics in Qatar
|
Dr. Amal Robay
|
|
Qatar Genome Polygenic Risk Score: A precision Medicine Approach to Prevent Diabetic Complications in the Local Population of Qatar (the 10,000 QGPRS Study)
|
Prof. Shahrad Taheri*
|
*WCM-Q serving as sub-awardee